Insider Transactions in Q3 2021 at Oyster Point Pharma, Inc. (OYST)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 02
2021
|
Daniel Lochner Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+13.13%
|
$82,500
$11.51 P/Share
|
|
Sep 01
2021
|
Jeffrey Nau President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+14.1%
|
$10,000
$1.02 P/Share
|
|
Jul 30
2021
|
Donald J Santel Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,114
+36.95%
|
-
|
|
Jul 28
2021
|
Daniel Lochner Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+15.11%
|
$82,500
$11.51 P/Share
|